Accuray (NASDAQ: ARAY)
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2022-08-10 | ||||||
REV |
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.040 | -0.010 | 0.0300 | ||||
REV | 97.280M | 96.169M | -1.111M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Accuray (NASDAQ: ARAY) through any online brokerage.
Other companies in Accuray’s space includes: NeuroPace (NASDAQ:NPCE), Axogen (NASDAQ:AXGN), Semler Scientific (NASDAQ:SMLR), Apollo Endosurgery (NASDAQ:APEN) and Lucid Diagnostics (NASDAQ:LUCD).
The latest price target for Accuray (NASDAQ: ARAY) was reported by BTIG on Friday, June 24, 2022. The analyst firm set a price target for 7.00 expecting ARAY to rise to within 12 months (a possible 257.14% upside). 3 analyst firms have reported ratings in the last year.
The stock price for Accuray (NASDAQ: ARAY) is $1.96 last updated June 30, 2022, 8:00 PM UTC.
There are no upcoming dividends for Accuray.
Accuray’s Q4 earnings are confirmed for Wednesday, August 10, 2022.
There is no upcoming split for Accuray.
Accuray is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.